Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.
Kotrotsou A, Elakkad A, Sun J, Thomas GA, Yang D, Abrol S, Wei W, Weinberg JS, Bakhtiari AS, Kircher MF, Luedi MM, de Groot JF, Sawaya R, Kumar AJ, Zinn PO, Colen RR.
Kotrotsou A, et al. Among authors: luedi mm.
J Neurooncol. 2018 Aug;139(1):125-133. doi: 10.1007/s11060-018-2850-4. Epub 2018 Apr 4.
J Neurooncol. 2018.
PMID: 29619649
Free article.